Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2024-04-08 | FEDERATED HERMES, INC. | Fusion Pharmaceuticals Inc. | 95,000 | 0.1% | EDGAR |
SC 13D | 2024-03-25 | FEDERATED HERMES, INC. | Fusion Pharmaceuticals Inc. | 10,716,153 | 12.6% | EDGAR |
SC 13G/A | 2024-03-11 | VANGUARD GROUP INC | FEDERATED HERMES, INC. | 8,690,618 | 10.3% | EDGAR |
SC 13G/A | 2024-03-06 | FEDERATED HERMES, INC. | Amphastar Pharmaceuticals, Inc. | 2,165,071 | 4.5% | EDGAR |
SC 13G/A | 2024-03-06 | FEDERATED HERMES, INC. | Merus N.V. | 2,297,700 | 4.0% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | FEDERATED HERMES, INC. | 8,532,465 | 9.9% | EDGAR |
SC 13G | 2024-02-09 | FMR LLC | FEDERATED HERMES, INC. | 5,593,701 | 6.5% | EDGAR |
SC 13G/A | 2024-02-07 | FEDERATED HERMES, INC. | P10, Inc. | 2,600,000 | 4.9% | EDGAR |
SC 13G/A | 2024-01-25 | BlackRock Inc. | FEDERATED HERMES, INC. | 8,110,763 | 9.4% | EDGAR |
SC 13G/A | 2024-01-18 | FEDERATED HERMES, INC. | DYNAVAX TECHNOLOGIES CORP | 11,364,666 | 8.8% | EDGAR |
SC 13G/A | 2024-01-18 | FEDERATED HERMES, INC. | Fusion Pharmaceuticals Inc. | 10,886,153 | 15.0% | EDGAR |
SC 13G/A | 2024-01-18 | FEDERATED HERMES, INC. | IDEAYA Biosciences, Inc. | 3,883,775 | 6.0% | EDGAR |
SC 13G/A | 2024-01-18 | FEDERATED HERMES, INC. | aTYR PHARMA INC | 10,169,600 | 17.4% | EDGAR |
SC 13G/A | 2024-01-18 | FEDERATED HERMES, INC. | Merus N.V. | 3,637,309 | 6.3% | EDGAR |
SC 13G/A | 2024-01-18 | FEDERATED HERMES, INC. | Minerva Neurosciences, Inc. | 1,351,275 | 19.3% | EDGAR |
SC 13G/A | 2024-01-18 | FEDERATED HERMES, INC. | P10, Inc. | 3,181,933 | 6.0% | EDGAR |
SC 13G/A | 2024-01-18 | FEDERATED HERMES, INC. | Regulus Therapeutics Inc. | 4,023,860 | 19.9% | EDGAR |
SC 13G/A | 2024-01-18 | FEDERATED HERMES, INC. | Rezolute, Inc. | 8,250,274 | 20.0% | EDGAR |
SC 13G/A | 2024-01-18 | FEDERATED HERMES, INC. | SCYNEXIS INC | 8,094,700 | 20.0% | EDGAR |
SC 13G/A | 2024-01-18 | FEDERATED HERMES, INC. | SOUNDTHINKING, INC. | 1,315,000 | 10.3% | EDGAR |